Atlas Trials

A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

Clinical trial NCT04659798 · COMPLETED

Trial details

NCT number
NCT04659798
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Start date
2021-01-22
Primary completion
2023-04-24
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.